Gillespie, Kathleen - University of Bristol - School of Clinical Sciences

研究领域

Genetic mechanisms underlying autoimmunity

近期论文

查看导师新发文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

Williams, G, Long, A, Wilson, I, Aitken, R, Wyatt, R, McDonald, TJ, Wong, S, Hattersley, AT, Williams, A, Bingley, P & Gillespie, K, 2016, ‘Beta cell function and ongoing autoimmunity in long-standing, childhood onset type 1 diabetes.’. Ye, J, Long, AE, Pearson, JA, Taylor, H, Bingley, PJ, Williams, AJK & Gillespie, KM, 2015, ‘Attenuated humoral responses in HLA-A*24-positive individuals at risk of type 1 diabetes’. Diabetologia, vol 58., pp. 2284-7 Ye, J & Gillespie, KM, 2015, ‘Fluorescence In Situ Hybridization with Concomitant Immunofluorescence in Human Pancreas’. Methods in Molecular Biology. Kozhakhmetova, A & Gillespie, KM, 2015, ‘Type 1 Diabetes: Current Perspectives’. Methods in Molecular Biology. Aitken, RJ, Mortimer, GL & Gillespie, KM, 2015, ‘Type 1 Diabetes High-Risk HLA Class II Determination by Polymerase Chain Reaction Sequence-Specific Primers’. Methods in Molecular Biology. Ye, J, Vives-Pi, M & Gillespie, KM, 2014, ‘Maternal Microchimerism: Increased in the Insulin Positive Compartment of Type 1 Diabetes Pancreas but Not in Infiltrating Immune Cells or Replicating Islet Cells’. PLoS ONE, vol 9. Ye, J & Gillespie, K, 2014, ‘Maternal microchimerism: Friend or foe in type 1 diabetes?’. Chimerism. Gillespie, KM, Aitken, RJ, Wilson, I, Williams, AJK & Bingley, PJ, 2013, ‘Early onset of diabetes in the proband is the major determinant of risk in HLA DR3-DQ2/DR4-DQ8 siblings’. Diabetes. Long, AE, Gillespie, KM, Aitken, RJ, Goode, JC, Bingley, PJ & Williams, AJK, 2013, ‘Humoral responses to islet antigen-2 and zinc transporter 8 are attenuated in patients carrying HLA-A *24 alleles at the onset of type 1 diabetes’. Diabetes, vol 62., pp. 2067-2071 Zeng, L, Jarrett, CE, Brown, KW, Gillespie, KM, Holly, JMP & Perks, CM, 2013, ‘Insulin-like growth factor binding protein-3 (IGFBP-3) plays a role in the anti-tumorigenic effects of 5-Aza-2′-deoxycytidine (AZA) in breast cancer cells’. Experimental Cell Research, vol 319., pp. 2282-2295